Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 616 AL 630

Emerging roles of innate and adaptive immunity in Alzheimer's disease

Chen X, Holtzman DM.

Immunity. 2022 Dec 13;55(12):2236-2254. doi: 10.1016/j.immuni.2022.10.016. Epub 2022 Nov 8.

Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect

Ferreira I, Rauter AP, Bandarra NM.

Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.

Hope on the horizon for Alzheimer's disease treatment?

The Lancet Healthy Longevity.

Lancet Healthy Longev. 2022 Nov;3(11):e722. doi: 10.1016/S2666-7568(22)00251-3.

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics

Avgerinos KI, Mullins RJ, Vreones M, Mustapic M, Chen Q, Melvin D, Kapogiannis D, Egan JM.

Cells. 2022 Oct 25;11(21):3372. doi: 10.3390/cells11213372.

The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer's Disease

Busch L, Eggert S, Endres K, Bufe B.

Cells. 2022 Oct 29;11(21):3421. doi: 10.3390/cells11213421.

Amyloid Beta in Aging and Alzheimer's Disease

Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH.

Int J Mol Sci. 2022 Oct 26;23(21):12924. doi: 10.3390/ijms232112924.

Microglia and Alzheimer's Disease

Merighi S, Nigro M, Travagli A, Gessi S.

Int J Mol Sci. 2022 Oct 27;23(21):12990. doi: 10.3390/ijms232112990.

Alzheimer's Disease: From Immune Homeostasis to Neuroinflammatory Condition

Princiotta Cariddi L, Mauri M, Cosentino M, Versino M, Marino F.

Int J Mol Sci. 2022 Oct 27;23(21):13008. doi: 10.3390/ijms232113008.

Long Non-Coding RNAs, Extracellular Vesicles and Inflammation in Alzheimer's Disease

Canseco-Rodriguez A, Masola V, Aliperti V, Meseguer-Beltran M, Donizetti A, Sanchez-Perez AM.

Int J Mol Sci. 2022 Oct 29;23(21):13171. doi: 10.3390/ijms232113171.

PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer's Disease

Yang Y, Bagyinszky E, An SSA, Kim S.

Int J Mol Sci. 2022 Nov 1;23(21):13331. doi: 10.3390/ijms232113331.

Astrocytes as a Therapeutic Target in Alzheimer's Disease-Comprehensive Review and Recent Developments

Rodríguez-Giraldo M, González-Reyes RE, Ramírez-Guerrero S, Bonilla-Trilleras CE, Guardo-Maya S, Nava-Mesa MO.

Int J Mol Sci. 2022 Nov 7;23(21):13630. doi: 10.3390/ijms232113630.

Does oxidative DNA damage trigger histotoxic hypoxia via PARP1/AMP-driven mitochondrial ADP depletion-induced ATP synthase inhibition in Alzheimer's disease?

Davis Sanders O, Rajagopal L, Chase Barton C, Archa Rajagopal J, Lopez O, Lopez K, Malik F.

Mitochondrion. 2022 Nov;67:59-64. doi: 10.1016/j.mito.2022.10.005. Epub 2022 Oct 29.

Veterans Health Administration Models of Community-Based Long-Term Care: State of the Science

McConnell ES, Xue TM, Levy CR.

J Am Med Dir Assoc. 2022 Dec;23(12):1900-1908.e7. doi: 10.1016/j.jamda.2022.10.012. Epub 2022 Nov 10.

Exploring New Vista for Alzheimer's Disease Drug Targets

Kumar D.

Curr Top Med Chem. 2022;22(22):1847-1848. doi: 10.2174/156802662222221007161622.

The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review

Ferreira D, Mohanty R, Murray ME, Nordberg A, Kantarci K, Westman E.

Acta Neuropathol Commun. 2022 Nov 14;10(1):166. doi: 10.1186/s40478-022-01471-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias